SCOR has been informed of the decision by Standard & Poor’s (S&P) to affirm the financial strength rating for the Group and its main subsidiaries at “AA-”, with a “stable outlook”, and to maintain the counterp
SCOR has been informed of the decision by Standard & Poor’s (S&P) to affirm the financial strength rating for the Group and its main subsidiaries at “AA-”, with a “stable outlook”, and to maintain the counterp
SCOR announces the following nominations across the Group:
At its annual Investor Day today in Paris, SCOR’s Executive Management team, led by Denis Kessler, presents an overview of the second successful year of the “Vision in Action” strategic plan and sets forth how the com
At its annual Investor Day today in Paris, SCOR’s Executive Management team, led by Denis Kessler, presents an overview of the second successful year of the “Vision in Action” strategic plan and sets forth how the com
Contrary to this assertion, SCOR has not held discussions with Partner Re nor any other company.
SCOR reaffirms its independence and acknowledges Covéa’s decision to withdraw its proposal on a potential combination.
SCOR reaffirms its independence and acknowledges Covéa’s decision to withdraw its proposal on a potential combination
SCOR formally denies the claim on the BFM business website that the Group has been in discussions with another partner for several months.
SCOR Global Life continues to promote health and wellness initiatives through a new partnership with Human Longevity, Inc.
Viral hepatitis is currently the world’s 7th deadliest human disease. To mark World Hepatitis Day on June 28, SCOR Global Life Medical Director Dr.
